Human papillomavirus (HPV) is a common sexually transmitted infection which is the cause
of several cancers, including cervical cancer, and genital warts. Although cervical cancer …

Recent data demonstrate that human papillomavirus also plays a role in cancers other than
ano-genital cancers, specifically head and neck cancers, and non-cancerous conditions …

This longitudinal study reports on the development and evaluation of a narrative intervention
aimed at increasing human papillomavirus (HPV) vaccination among college women. The …

Background Completion of multiple dose vaccine schedules is crucial to ensure a protective
immune response, and maximise vaccine cost-effectiveness. While barriers and facilitators …

Objectives: With recent approval of standalone HPV testing and increasing uptake of HPV
vaccination, some have postulated that we are moving toward a “post-Pap” era of cervical …

OBJECTIVE: To identify factors associated with initiation of the human papillomavirus
vaccine series and parental report of a healthcare provider recommendation of the human …

Background: The initiation and timely completion of the human papillomavirus (HPV)
vaccine in young women is critical. We compared the initiation and completion of the HPV …

Background While HPV vaccination uptake in Sweden is quite high, at around 80%, vaccine
hesitancy remains an issue in countries throughout Europe. The latter can be related to a …

Human papillomavirus (HPV) is currently the most common sexually transmitted disease in
the United States, with potentially serious health consequences, including cervical cancer …

Objectives Although racial and ethnic differences in HPV vaccination initiation are well
established, it is unclear whether these disparities have changed over time. The role of …